WDL-IL Overview
White Dog Labs Israel (WDL-IL) is developing technologies and products in industrial biology and industrial microbiology. The company has demonstrated proof of concept for its technologies for isolating and screening for new clostridia strains as potential probiotics for poultry, swine, and shrimp. It uses a proprietary process, Protocol B, for the isolation, selection, and cultivation of microbiome-derived Clostridia, which has resulted in large, diverse, and novel strain libraries. WDL-IL is a subsidiary of White Dog Labs (USA), a company dedicated to the research and development of sustainable chemicals and biofuels.
Latest News
No news articles.
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | — |
| Rounds | — |
| Investors | — |
Team Members
0
Web & Social Links
| Website | www.superbrewedfood.com |
Photos & Videos
No files yet
WDL-IL Business
Sector
—Target Customer
—Core Technology
—WDL-IL Financials
WDL-IL Lifecycle
WDL-IL News
0 articlesNo news articles.
WDL-IL Team
No team members listed.
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
WDL-IL Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 98/100 |
| Missing | funding rounds, markets |
| Last update | 2020-03-03T00:00:00.000Z |
| Claimed | Yes |
| Hidden | Pending approval (visible: 0) |